Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 601 to 605 of 605 entries
Sorted by: Best Match Show Resources per page
Impact of Atrial Fibrillation on Outcomes of Aortic Valve Implantation.

The American journal of cardiology

Ahmed R, Sawatari H, Deshpande S, Khan H, Rui P, Khanji MY, Sherif AA, Jaliparthy K, Reddy S, Nkomo VT, Manjunath CN, Yong-Mei C, Somers VK, Brady PA, Chahal AA, Padmanabhan D.
PMID: 34772477
Am J Cardiol. 2022 Jan 15;163:50-57. doi: 10.1016/j.amjcard.2021.09.036. Epub 2021 Nov 10.

New or preexisting atrial fibrillation (AF) is frequent in patients undergoing aortic valve replacement. We evaluated whether the presence of AF during transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR) impacts the length of stay, healthcare...

Cite
Ahmed R, Sawatari H, Deshpande S, et al. Impact of Atrial Fibrillation on Outcomes of Aortic Valve Implantation. Am J Cardiol. 2021;163:50-57doi: 10.1016/j.amjcard.2021.09.036.
Ahmed, R., Sawatari, H., Deshpande, S., Khan, H., Rui, P., Khanji, M. Y., Sherif, A. A., Jaliparthy, K., Reddy, S., Nkomo, V. T., Manjunath, C. N., Yong-Mei, C., Somers, V. K., Brady, P. A., Chahal, A. A., & Padmanabhan, D. (2022). Impact of Atrial Fibrillation on Outcomes of Aortic Valve Implantation. The American journal of cardiology, 16350-57. https://doi.org/10.1016/j.amjcard.2021.09.036
Ahmed, Raheel, et al. "Impact of Atrial Fibrillation on Outcomes of Aortic Valve Implantation." The American journal of cardiology vol. 163 (2022): 50-57. doi: https://doi.org/10.1016/j.amjcard.2021.09.036
Ahmed R, Sawatari H, Deshpande S, Khan H, Rui P, Khanji MY, Sherif AA, Jaliparthy K, Reddy S, Nkomo VT, Manjunath CN, Yong-Mei C, Somers VK, Brady PA, Chahal AA, Padmanabhan D. Impact of Atrial Fibrillation on Outcomes of Aortic Valve Implantation. Am J Cardiol. 2022 Jan 15;163:50-57. doi: 10.1016/j.amjcard.2021.09.036. Epub 2021 Nov 10. PMID: 34772477.
Copy Download .nbib Format: NLM
Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

The American journal of cardiology

Maron MS, Rastegar H, Dolan N, Carpino P, Koethe B, Maron BJ, Rowin EJ.
PMID: 34785034
Am J Cardiol. 2022 Jan 15;163:91-97. doi: 10.1016/j.amjcard.2021.09.040. Epub 2021 Nov 14.

For over 50 years, surgical septal myectomy has been the preferred treatment for drug-refractory heart failure symptoms in obstructive hypertrophic cardiomyopathy (HCM). However, given the relatively youthful adult ages at which HCM surgery is usually performed, it is informative...

Cite
Maron MS, Rastegar H, Dolan N, et al. Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2021;163:91-97doi: 10.1016/j.amjcard.2021.09.040.
Maron, M. S., Rastegar, H., Dolan, N., Carpino, P., Koethe, B., Maron, B. J., & Rowin, E. J. (2022). Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy. The American journal of cardiology, 16391-97. https://doi.org/10.1016/j.amjcard.2021.09.040
Maron, Martin S, et al. "Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy." The American journal of cardiology vol. 163 (2022): 91-97. doi: https://doi.org/10.1016/j.amjcard.2021.09.040
Maron MS, Rastegar H, Dolan N, Carpino P, Koethe B, Maron BJ, Rowin EJ. Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2022 Jan 15;163:91-97. doi: 10.1016/j.amjcard.2021.09.040. Epub 2021 Nov 14. PMID: 34785034.
Copy Download .nbib Format: NLM
Morphologic Findings in Native Mitral Valves Replaced for Isolated Acute Infective Endocarditis.

The American journal of cardiology

Roberts WC, Salam YM, Roberts CS.
PMID: 34903338
Am J Cardiol. 2022 Jan 01;162:136-142. doi: 10.1016/j.amjcard.2021.08.053.

Described here are some clinical and morphological observations in 37 adults having mitral valve replacement for active infective endocarditis limited to the mitral valve. The operatively-excised mitral valves are illustrated in 11 of the 37 patients, and photographs in...

Cite
Roberts WC, Salam YM, Roberts CS. Morphologic Findings in Native Mitral Valves Replaced for Isolated Acute Infective Endocarditis. Am J Cardiol. 2022;162:136-142doi: 10.1016/j.amjcard.2021.08.053.
Roberts, W. C., Salam, Y. M., & Roberts, C. S. (2022). Morphologic Findings in Native Mitral Valves Replaced for Isolated Acute Infective Endocarditis. The American journal of cardiology, 162136-142. https://doi.org/10.1016/j.amjcard.2021.08.053
Roberts, William C, et al. "Morphologic Findings in Native Mitral Valves Replaced for Isolated Acute Infective Endocarditis." The American journal of cardiology vol. 162 (2022): 136-142. doi: https://doi.org/10.1016/j.amjcard.2021.08.053
Roberts WC, Salam YM, Roberts CS. Morphologic Findings in Native Mitral Valves Replaced for Isolated Acute Infective Endocarditis. Am J Cardiol. 2022 Jan 01;162:136-142. doi: 10.1016/j.amjcard.2021.08.053. PMID: 34903338.
Copy Download .nbib Format: NLM
Characterization of Circulating and Urinary Biomarkers in the Fontan Circulation and Their Correlation With Cardiac Imaging.

The American journal of cardiology

Ghelani SJ, Opotowsky AR, Harrild DM, Powell AJ, Azcue N, Ahmad S, Clair NS, Bradwin G, Rathod RH.
PMID: 34903340
Am J Cardiol. 2022 Jan 01;162:177-183. doi: 10.1016/j.amjcard.2021.08.063.

Several circulating biomarkers have been found to play a role in the surveillance and risk stratification of heart failure without congenital heart disease, but these have not been widely studied in patients with single ventricles palliated with a Fontan...

Cite
Ghelani SJ, Opotowsky AR, Harrild DM, et al. Characterization of Circulating and Urinary Biomarkers in the Fontan Circulation and Their Correlation With Cardiac Imaging. Am J Cardiol. 2022;162:177-183doi: 10.1016/j.amjcard.2021.08.063.
Ghelani, S. J., Opotowsky, A. R., Harrild, D. M., Powell, A. J., Azcue, N., Ahmad, S., Clair, N. S., Bradwin, G., & Rathod, R. H. (2022). Characterization of Circulating and Urinary Biomarkers in the Fontan Circulation and Their Correlation With Cardiac Imaging. The American journal of cardiology, 162177-183. https://doi.org/10.1016/j.amjcard.2021.08.063
Ghelani, Sunil J, et al. "Characterization of Circulating and Urinary Biomarkers in the Fontan Circulation and Their Correlation With Cardiac Imaging." The American journal of cardiology vol. 162 (2022): 177-183. doi: https://doi.org/10.1016/j.amjcard.2021.08.063
Ghelani SJ, Opotowsky AR, Harrild DM, Powell AJ, Azcue N, Ahmad S, Clair NS, Bradwin G, Rathod RH. Characterization of Circulating and Urinary Biomarkers in the Fontan Circulation and Their Correlation With Cardiac Imaging. Am J Cardiol. 2022 Jan 01;162:177-183. doi: 10.1016/j.amjcard.2021.08.063. PMID: 34903340.
Copy Download .nbib Format: NLM
Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study).

The American journal of cardiology

Alfonso F, Cuesta J, Ojeda S, Camacho-Freire S, García Del Blanco B, Vaquerizo B, Zueco J, Trillo R, Mauri J, Velázquez M, Córdoba-Soriano JG, Serra A, Navarro F, Pan M, Díaz J, Otaegui I, Salvatella N, De la TorreHernandez JM, Val DD, Bastante T, Rivero F.
PMID: 34903344
Am J Cardiol. 2022 Jan 01;162:31-40. doi: 10.1016/j.amjcard.2021.09.027.

Currently, both drug-eluting stents (DES) and drug-eluting balloons are recommended in patients with in-stent restenosis (ISR) of metallic stents. However, the clinical results of repeated interventions in patients with restenosis of bioresorbable vascular scaffolds (BVS) remain unsettled. We sought...

Cite
Alfonso F, Cuesta J, Ojeda S, et al. Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study). Am J Cardiol. 2022;162:31-40doi: 10.1016/j.amjcard.2021.09.027.
Alfonso, F., Cuesta, J., Ojeda, S., Camacho-Freire, S., García Del Blanco, B., Vaquerizo, B., Zueco, J., Trillo, R., Mauri, J., Velázquez, M., Córdoba-Soriano, J. G., Serra, A., Navarro, F., Pan, M., Díaz, J., Otaegui, I., Salvatella, N., De la TorreHernandez, J. M., Val, D. D., Bastante, T., Rivero, F. (2022). Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study). The American journal of cardiology, 16231-40. https://doi.org/10.1016/j.amjcard.2021.09.027
Alfonso, Fernando, et al. "Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study)." The American journal of cardiology vol. 162 (2022): 31-40. doi: https://doi.org/10.1016/j.amjcard.2021.09.027
Alfonso F, Cuesta J, Ojeda S, Camacho-Freire S, García Del Blanco B, Vaquerizo B, Zueco J, Trillo R, Mauri J, Velázquez M, Córdoba-Soriano JG, Serra A, Navarro F, Pan M, Díaz J, Otaegui I, Salvatella N, De la TorreHernandez JM, Val DD, Bastante T, Rivero F. Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study). Am J Cardiol. 2022 Jan 01;162:31-40. doi: 10.1016/j.amjcard.2021.09.027. PMID: 34903344.
Copy Download .nbib Format: NLM
Showing 601 to 605 of 605 entries